| The global emergency of novel coronavirus (SARS-CoV-2): An update of the current status and forecasting H Hozhabri, F Piceci Sparascio, H Sohrabi, L Mousavifar, R Roy, ... International journal of environmental research and public health 17 (16), 5648, 2020 | 97 | 2020 |
| Development of Mannopyranoside Therapeutics against Adherent-Invasive Escherichia coli Infections L Mousavifar, M Touaibia, R Roy Accounts of chemical research 51 (11), 2937-2948, 2018 | 31 | 2018 |
| Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin M Touaibia, EM Krammer, TC Shiao, N Yamakawa, Q Wang, A Glinschert, ... Molecules 22 (7), 1101, 2017 | 31 | 2017 |
| Design, Synthetic Strategies, and Therapeutic Applications of Heterofunctional Glycodendrimers RR Leila Mousavifar Molecules 26, 2428, 2021 | 20 | 2021 |
| Aberrant glycosylation patterns on cancer cells: Therapeutic opportunities for glycodendrimers/metallodendrimers oncology S Moffett, TC Shiao, L Mousavifar, S Mignani, R Roy Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 13 (1 …, 2021 | 18 | 2021 |
| Recent development in the design of small ‘drug-like’and nanoscale glycomimetics against Escherichia coli infections L Mousavifar, R Roy Drug Discovery Today 26 (9), 2124-2137, 2021 | 16 | 2021 |
| Synthesis of Highly Functionalized Isoxazolinediones from One-Pot Reaction of Alkylidene Meldrum′s Acid with Alkyl Isocyanides in the Presence of Arylhydroxylamines A Habibi, L Mousavifar, I Yavari, MR Yazdanbakhsh Monatshefte fuer Chemie 138 ((6)), 603-606, 2007 | 15 | 2007 |
| Comparative Study of Aryl O-, C-, and S-Mannopyranosides as Potential Adhesion Inhibitors toward Uropathogenic E. coli FimH L Mousavifar, G Vergoten, G Charron, R Roy Molecules 24 (19), 3566, 2019 | 11 | 2019 |
| Synthesis of 1‐(2,6‐Dimethylphenyl)‐N‐hydroxy‐4,4‐dialkyl‐2,5‐dioxo‐N‐aryl‐3‐pyrrolidine‐carboxamides from Reaction of 2,6‐Dimethylphenyl Isocyanide … A Habibi, L Mousavifar, MR Yazdanbakhsh, I Yavari Synthetic Communications 38 (6), 873-880, 2008 | 10 | 2008 |
| Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposome AL Martel, NL Fraleigh, E Picard, JD Lewicky, G Pawelec, H Lee, GW Ma, ... International Journal of Pharmaceutics 606, 120849, 2021 | 8 | 2021 |
| Improving the utility of a dynorphin peptide analogue using mannosylated glycoliposomes JD Lewicky, NL Fraleigh, AL Martel, TMD Nguyen, PW Schiller, ... International Journal of Molecular Sciences 22 (15), 7996, 2021 | 7 | 2021 |
| Alternative therapeutic strategies to fight bacterial infections L Mousavifar, R Roy Frontiers Drug Chemistry Clinical Res 13, 25, 2018 | 7 | 2018 |
| Synthesis & Evaluation of Novel Mannosylated Neoglycolipids for Liposomal Delivery System Applications Leila Mousavifar , Jordan D. Lewicky , Alexis Taponard , Rahul Bagul ... Pharmaceutics 14 (2300), 2022 | 5 | 2022 |
| Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists L Mousavifar, M Sarshar, C Bridot, D Scribano, C Ambrosi, AT Palamara, ... Pharmaceutics 15 (2), 527, 2023 | 4 | 2023 |
| Carrier diversity and chemical ligations in the toolbox for designing tumor-associated carbohydrate antigens (TACAs) as synthetic vaccine candidates R Roy, L Mousavifar Chemical Society Reviews, 2023 | 4 | 2023 |
| Deciphering the conformation of C-linked α-D-mannopyranosides and their application toward the synthesis of low nanomolar E. coli FimH ligands L Mousavifar, G Vergoten, R Roy ARKIVOC: Free Online Journal of Organic Chemistry 2018 (7), 384-397, 2018 | 4 | 2018 |
| Validation of Selective Capture of Fimbriated Uropathogenic Escherichia coli by a Label-free Engineering Detection System Using Mannosylated Surfaces L Mousavifar, P Parreira, A Taponard, VCD Graça, MCL Martins, R Roy ACS Applied Bio Materials 5 (12), 5877-5886, 2022 | 3 | 2022 |
| Recent Development in the Design of Neoglycoliposomes Bearing Arborescent Architectures SARR Leila Mousavifar Molecules, 4281, 2021 | 3 | 2021 |
| Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy JD Lewicky, AL Martel, NL Fraleigh, E Picard, L Mousavifar, A Nakamura, ... Pharmaceutics 14 (12), 2710, 2022 | 2 | 2022 |
| Crystal Structure of N-(tert-Butyl)-1-(3,5-dioxo-2-phenyltetrahydro-4-isoxazolyl)cyclohexane Carboxamide A Habibi, MR Yazdanbakhsh, L Mousavifar Journal of Chemical Crystallography 38, 701-704, 2008 | 1 | 2008 |
René RoyProfesseur de chimie, Université du Québec à MontréalAdresse e-mail validée de uqam.ca
